Growth hormone (GH) treatment reduces peripheral thyroid hormone action in girls with Turner syndrome

Clinical Endocrinology

Volumn 67, Issue 4, 2007, Pages 629-636

  Susperreguy, S ^a   Miras, M B ^b   Montesinos, M M ^a   Mascanfroni, I D ^a   Munoz L ^b   Sobrero, G ^b   Silvano, L ^b   Masini Repiso, A M ^a   Coleoni, A H ^a   Targovnik, H M ^c   Pellizas, C G ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Hospital de Ninos de la Santisima Trinidad   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; HUMAN GROWTH HORMONE; MESSENGER RNA; SOMATOMEDIN C; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; THYROID FUNCTION; TREATMENT DURATION; TREATMENT RESPONSE; TURNER SYNDROME;

ACTINS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; COLLAGEN; DEPRESSION, CHEMICAL; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OSTEOCALCIN; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX HORMONE-BINDING GLOBULIN; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; THYROID HORMONES; THYROTROPIN; TRIIODOTHYRONINE; TURNER SYNDROME;

EID: 34548663889     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02936.x     Document Type: Article

References (40)

1. Sybert, V.P. McCauley, E. (2004) Turner's syndrome. New England Journal of Medicine, 351, 1227 1238.
2. Gravholt, C.H. (2004) Epidemiological, endocrine and metabolic features in Turner syndrome. European Journal of Endocrinology, 151, 657 687.
3. Dacou-Voutetakis, C., Karavanaki-Karanassiou, K., Petrou, V., Georgopoulos, N., Maniati-Christidi, M. Mavrou, A. (1998) The growth pattern and final height of girls with Turner syndrome with and without human growth hormone treatment. Pediatrics, 101, 663 668.
4. Cave, C.B., Bryant, J. Milne, R. (2003) Recombinant growth hormone in children and adolescents with Turner syndrome. Cochrane Database System Review CD003887.
5. The Canadian Growth Hormone Advisory Committee (2005) Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. Journal of Clinical Endocrinology and Metabolism, 90, 3360 3366.
6. Darendeliler, F., Ranke, M.B., Bakker, B., Lindberg, A., Cowell, C.T., Albertsson-Wikland, K., Reiter, E.O. Price, D.A. (2004) Bone age progression during the first year of GH therapy in pre-pubertal children with idiopathic GH deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Hormone Research, 63, 40 47.
7. Harvey, C.B., O'Shea, P.J., Scott, A.J., Robson, H., Siebler, T., Shalet, S.M., Samarut, J., Chassande, O. Williams, G.R. (2002) Molecular mechanisms of thyroid hormone effects on bone growth and function. Molecular Genetics and Metabolism, 75, 17 30.
8. Davis, P.J., Davis, F.B. Cody, V. (2005) Membrane receptors mediating thyroid hormone action. Trends in Endocrinology and Metabolism, 16, 429 435.
9. Yen, P.M., Ando, S., Feng, X., Liu, Y. Maruvada, P. (2006) Thyroid hormone action at the cellular, genomic and target gene levels. Molecular and Cellular Endocrinology, 246, 121 127.
10. -/- mice. Journal of Endocrinology, 171, 15 22.
11. O'Shea, P.J., Bassett, J.H., Sriskantharajah, S., Ying, H., Cheng, S.Y. Williams, G.R. (2005) Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta. Molecular Endocrinology, 19, 3045 3059.
12. Jorgensen, J.O.L., Moller, J., Laureen, T., Orskov, H., Christiansen, J.S. Weeke, J. (1994) Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clinical Endocrinology, 41, 609 614.
13. Bettendorf, M., Doerr, H.G., Hauffa, B.P., Lindberg, A., Mehls, O., Partsch, C.J., Schwarz, H.P., Stahnke, N. Ranke, M.B. (2006) Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment. Journal of Pediatric Endocrinology and Metabolism, 19, 149 154.
14. Pellizas, C.G., Coleoni, A.H., Cabanillas, A.M., Masini-Repiso, A.M. Costamagna, M.E. (1996) Response of triiodothyronine-dependent enzyme activities to insulin-like growth factor I and growth hormone in cultured rat hepatocytes. European Journal of Endocrinology, 134, 215 220.
15. Pellizas, C.G., Coleoni, A.H., Costamagna, M.E., Di Fulvio, M. Masini-Repiso, A.M. (1998) Insulin-like growth factor I reduces thyroid hormone receptors in the rat liver: evidence for a feedback loop regulating the peripheral thyroid hormone action. Journal of Endocrinology, 158, 87 95.
16. Pellizas, C.G., Bonaterra, M., De Paul, A.L., Aoki, A., Coleoni, A.H. Torres, A.I. (2000) Somatotroph response to periodical IGF-I administration to male rats. Acta Histochemica, 102, 439 451.
17. Pellizas, C.G., Montesinos, M.M., Masini-Repiso, A.M., Torres, A.I. Coleoni, A.H. (2002) Differential modulation of liver and pituitary triiodothyronine and 9-cis retinoid acid receptors by insulin-like growth factor I in rats. Thyroid, 12, 1071 1078.
18. Nagayama, Y., Yamashita, S., Hirayu, H., Ashizawa, K., Harakawa, S., Inoue, S., Izumi, M. Nagataki, S. (1988) Expression and regulation of c-erb A mRNA from lymphocytes in patients with thyroid dysfunction. Endocrinologia Japonica, 35, 463 467.
19. 1 triiodothyronine receptor mRNA in human tissues by competitive reverse transcription polymerase chain reaction. Journal of Endocrinological Investigation, 18, 767 773.
20. Feart, C., Pallet, V., Boucheron, C., Higheret, D., Alfos, S., Leteneur, L., Dartigues, J.F. Higueret, P. (2005a) Aging affects the retinoid acid and the triiodothyronine nuclear receptor mRNA expression in human peripheral blood mononuclear cells. European Journal of Endocrinology, 152, 449 458.
21. Feart, C., Vallortigara, J., Higueret, D., Gatta, B., Tabarin, A., Enderlin, V., Higueret, P. Pallet, V. (2005b) Decreased expression of retinoid nuclear receptor (RARα and RARγ) mRNA determined by real-time quantitative RT-PCR in peripheral blood mononuclear cells of hypothyroid patients. Journal of Molecular Endocrinology, 34, 849 858.
22. Regalbuto, C., Alagona, C., Maiorana, R., Di Paola, R., Cianci, M., Alagona, G., Sapienza, S., Vigneri, R. Pezzino, V. (2006) Acute changes in clinical parameters and thyroid function peripheral markers following L-T4 withdrawal in patients totally thyroidectomized for thyroid cancer. Journal of Endocrinological Investigation, 29, 32 40.
23. Seppel, T., Becker, A., Lippert, F. Schlaghecke, R. (1996) Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations. Journal of Clinical Endocrinology and Metabolism, 81, 1663 1665.
24. Massa, G., de Zegher, F. Vanderschueren-Lodeweyckx, M. (1991) Effect of growth hormone therapy on thyroid status of girls with Turner's syndrome. Clinical Endocrinology, 34, 205 209.
25. Schmitt, K., Hausler, G., Blumel, P., Plochl, E., Waldhor, T. Frisch, H. (1997) The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome. European Journal of Pediatrics, 156, 99 103.
26. Wyatt, D., Gesundheit, N. Sherman, B. (1998) Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation. Journal of Clinical Endocrinology and Metabolism, 83, 3493 3497.
27. Morimura, T., Tsunekawa, K., Kasahara, T., Seki, K., Ogiwara, T., Mori, M. Murakami, M. (2005) Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin. Endocrinology, 146, 2077 2084.
28. Ercan-Fang, S., Schwartz, H.L. Oppenheimer, J.H. (1996) Isoform-specific 3,5,3′-triiodothyronine receptor binding capacity and messenger ribonucleic acid content in rat adenohypophysis: effect of thyroidal state and comparison with extrapituitary tissues. Endocrinology, 137, 3228 3233.
29. Gauthier, K., Chassande, O., Plateroti, M., Roux, J.P., Legrand, C., Pain, B., Rousset, B., Weiss, R., Trouillas, J. Samarut, J. (1999) Different functions for the thyroid hormone receptors TRα and TRβ in the control of thyroid hormone production and post-natal development. EMBO Journal, 18, 623 631.
30. Sato, T., Suzuki, Y., Taketani, T., Ishiguro, K. Masuyama, T. (1977) Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children. Journal of Clinical Endocrinology and Metabolism, 45, 324 329.
31. Kalina-Faska, B., Kalina, M. Koehler, B. (2002) Assessment of thyrotropin concentrations in children with somatotropin deficiency treated with growth hormone. Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego, 8, 17 21.
32. MacGillivray, M.H. (1995) Disorders of growth and development. In : P. Felig, J.D. Baxter, L.A. Frohman eds. Endocrinology and Metabolism, 3rd edn. McGraw-Hill, New York, 1619 1673
33. Hampl, R., Snajderova, M., Lebl, J., Lisa, L., Dvorakova, M., Hill, M., Sulcova, J. Starka, L. (2001) Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome. Endocrine Regulations, 35, 17 24.
34. Beck-Peccoz, P. Chatterjee, K. (1994) The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid, 4, 225 232.
35. Haeusler, G., Schmitt, K., Blumel, P., Plochl, E., Waldhor, T.H. Frisch, H. (1996) Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. Journal of Clinical Endocrinology and Metabolism, 81, 536 541.
36. Belgorosky, A., Martinez, A., Domene, H., Heinrich, J.J., Bergada, C. Rivarola, M.A. (1987) High serum sex hormone-binding globulin (SHBG) and low serum nonbound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment. Journal of Clinical Endocrinology and Metabolism, 65, 1107 1111.
37. Gafny, M., Silbergeld, A., Klinger, B., Wasserman, M. Laron, Z. (1994) Comparative effects of GH, IGF-I and insulin on serum sex hormone binding globulin. Clinical Endocrinology, 41, 169 175.
38. Rosen, H.N., Moses, A.C., Garber, J., Iloputaife, I.D., Ross, D.S., Lee, S.L., Greenspan, S. L. (2000) Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcified Tissue International, 66, 100 103.
39. Baroncelli, G.I., Bertelloni, S., Ceccarelli, C., Cupelli, D. Saggese, G. (2000) Dynamics of bone turnover in children with GH deficiency treated with GH until final height. European Journal of Endocrinology, 142, 549 556.
40. Gravholt, C.H., Naeraa, R.W., Brixen, K., Kastrup, K.W., Mosekilde, L., Jorgensen, J.O. Christiansen, J.S. (2002) Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics, 110, 889 896.